{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:13:16Z","timestamp":1793765596612,"version":"4.6.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Spread of botulinum toxin outside the treated muscle is a concern, when energy-based device treatment is performed on the same day as toxin injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>We assessed the frequency of eyelid ptosis after the glabella\/periorbital botulinum toxin injection and nonablative fractionated laser performed at the same session.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS AND MATERIALS<\/jats:title>\n            <jats:p>This single-center, retrospective study identified treatments consisting of glabella and\/or periorbital botulinum toxin injection and nonablative fractionated laser treatment to full face from 2017 to 2019 and eyelid ptosis determined by documentation of the complication at a follow-up encounter, or prescription of apraclonidine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Six hundred sixteen treatments of glabella\/periorbital botulinum toxin injection and full-face nonablative fractionated laser on the same day on 393 individuals were identified. Five hundred eighty treatments (94%) included botulinum toxin injected in the glabella, 541 (88%) in the periorbital areas, and 508 (82%) in the forehead. Nonablative fractionated lasers used to treat the cohort were a 1,927-nm thulium and a 1,550-nm er:glass laser. Eyelid ptosis complication was documented in one case (0.2%) following the combined laser and toxin treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The risk of spread of glabella\/periorbital botulinum toxin to an unintended muscle was minimal in the setting of the concomitant full-face nonablative fractionated laser.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002851","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T15:03:06Z","timestamp":1604847786000},"page":"500-503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Safety Profile of Combined Same-Day Treatment for Botulinum Toxin With Full Face Nonablative Fractionated Laser Resurfacing"],"prefix":"10.1097","volume":"47","author":[{"given":"Hyemin","family":"Pomerantz","sequence":"first","affiliation":[{"name":"Laser and Skin Surgery Center of New York, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Akintilo","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Shaw","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Lederhandler","sequence":"additional","affiliation":[{"name":"Laser and Skin Surgery Center of New York, New York, New York;"},{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Anolik","sequence":"additional","affiliation":[{"name":"Laser and Skin Surgery Center of New York, New York, New York;"},{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy G.","family":"Geronemus","sequence":"additional","affiliation":[{"name":"Laser and Skin Surgery Center of New York, New York, New York;"},{"name":"The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.iio.0000167162.33503.ad","article-title":"Adjunctive botulinum toxin type A: fillers and light-based therapies","volume":"45","author":"Carruthers","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1524-4725.1999.08244.x","article-title":"Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing","volume":"25","author":"West","year":"1999","journal-title":"Dermatol Surg"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archfaci.3.3.165","article-title":"Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial","volume":"3","author":"Zimbler","year":"2001","journal-title":"Arch Facial Plast Surg"},{"key":"R4-20250731","first-page":"355","article-title":"The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet Botulinum toxin type A chemodenervation","volume":"30","author":"Carruthers","year":"2004","journal-title":"Dermatol Surg"},{"key":"R5-20250731","first-page":"1062","article-title":"The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study","volume":"34","author":"Khoury","year":"2008","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"R6-20250731","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/DSS.0000000000000740","article-title":"Rejuvenation of the upper face and periocular region: combining neuromodulator, facial filler, laser, light, and energy-based therapies for optimal results","volume":"42","author":"Langelier","year":"2016","journal-title":"Dermatol Surg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/jocd.13266","article-title":"Complications of botulinum toxin and fillers: a narrative review","volume":"19","author":"Kassir","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1190.e1","DOI":"10.1016\/j.joms.2020.02.016","article-title":"What are the most commonly reported complications w ith cosmetic botulinum toxin type A treatments?","volume":"78","author":"Lee","year":"2020","journal-title":"J Oral Maxillo Fac Surg"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/sder.2001.25138","article-title":"Botulinum toxin type A: history and current cosmetic use in the upper face","volume":"20","author":"Carruthers","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/14764172.2014.968578","article-title":"Are combined same-day treatments the future for photorejuvenation? Review of the literature on combined treatments with lasers, intense pulsed light, radiofrequency, botulinum toxin, and fillers for rejuvenation","volume":"17","author":"Cuerda-Galindo","year":"2015","journal-title":"J Cosmet Laser Ther"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00042728-200504000-00005","article-title":"Does laser inactivate botulinum toxin?","volume":"31","author":"Semchyshyn","year":"2005","journal-title":"Dermatol Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dsu.12463","article-title":"Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies","volume":"40","author":"Cavallini","year":"2014","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00266-016-0682-1","article-title":"Adverse events of botulinum toxin type A in facial rejuvenation: a systemic review and meta-analysis","volume":"40","author":"Jia","year":"2016","journal-title":"Aesth Plast Surg"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"248e","DOI":"10.1097\/PRS.0b013e3181ef822a","article-title":"Mechanisms of blepharoptosis following cosmetic glabellar chemodenervation","volume":"126","author":"Ramey","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/DSS.0000000000000386","article-title":"Persistence of upper blepharoptosis after cosmetic botulinum toxin type A","volume":"41","author":"Steinsapir","year":"2015","journal-title":"Dermatol Surg"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2017.03.025","article-title":"Apraclonidine in the treatment of ptosis","volume":"376","author":"Wijemanne","year":"2017","journal-title":"J Neurol Sci"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jbiomech.2007.11.016","article-title":"Botox produces functional weakness in non-injected muscles adjacent to the target muscle","volume":"41","author":"Yaraskavitch","year":"2008","journal-title":"J Biomech"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov Disord"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14764170410023767","article-title":"Botulinum toxin A gives adjunctive benefit to periorbital laser resurfacing","volume":"6","author":"Yamauchi","year":"2004","journal-title":"J Cosmet Laser Ther"},{"key":"R20-20250731","first-page":"1151","article-title":"Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek","volume":"6","author":"Beer","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.PRS.0000076504.79727.62","article-title":"Doubleblind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines","volume":"112","author":"Carruthers","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1524-4725.2009.01390.x","article-title":"Botulinum toxin Type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study","volume":"36","author":"Wu","year":"2010","journal-title":"Dermatol Surg"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/j.1524-4725.2009.01235.x","article-title":"Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: efficacy and safety","volume":"35","author":"Brandt","year":"2009","journal-title":"Dermatol Surg"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.asj.2009.09.003","article-title":"An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines","volume":"29","author":"Cohen","year":"2009","journal-title":"Aesthet Surg J"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","article-title":"A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose","volume":"33","author":"Monheit","year":"2007","journal-title":"Dermatol Surg"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","article-title":"Evaluation of variable-dose treatment with a new U.S. botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebocontrolled study","volume":"124","author":"Kane","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archfaci.2009.5","article-title":"Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines","volume":"11","author":"Moy","year":"2009","journal-title":"Arch Facial Plast Surg"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1524-4725.2009.01261.x","article-title":"Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study","volume":"35","author":"Ascher","year":"2009","journal-title":"Dermatol Surg"},{"key":"R30-20250731","first-page":"461","article-title":"A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides","volume":"29","author":"Carruthers","year":"2003","journal-title":"Dermatol Surg"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaad.2009.01.005","article-title":"A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy","volume":"60","author":"Carruthers","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1473-2165.2007.00325.x","article-title":"Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience","volume":"6","author":"Farahvash","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1524-4725.2006.32327.x","article-title":"Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients","volume":"33","author":"Rzany","year":"2007","journal-title":"Dermatol Surg"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4725.2006.32326.x","article-title":"Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes","volume":"33","author":"Carruthers","year":"2007","journal-title":"Dermatol Surg"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","article-title":"Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg","volume":"40","author":"Carli","year":"2009","journal-title":"Muscle Nerve"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1473-2165.2008.00361.x","article-title":"Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study","volume":"7","author":"Cliff","year":"2008","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl 1","key":"R37-20250731","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17429590701523794","article-title":"Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications","volume":"9","author":"De Almeida","year":"2007","journal-title":"J Cosmet Laser Ther"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.143.11.1447-b","article-title":"A randomized double-blind study of the effect of botox and dysport\/reloxin on forehead wrinkles and electromyographic activity","volume":"143","author":"Karsai","year":"2007","journal-title":"Arch Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:13:02Z","timestamp":1753999982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002851","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}